Annual Shareholders Equity
$584.61 M
+$84.97 M+17.01%
31 December 2023
Summary:
Iovance Biotherapeutics annual stockholders equity is currently $584.61 million, with the most recent change of +$84.97 million (+17.01%) on 31 December 2023. During the last 3 years, it has fallen by -$71.89 million (-10.95%). IOVA annual shareholders equity is now -10.95% below its all-time high of $656.50 million, reached on 31 December 2020.IOVA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$773.46 M
+$4.92 M+0.64%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly stockholders equity is currently $773.46 million, with the most recent change of +$4.92 million (+0.64%) on 30 September 2024. Over the past year, it has increased by +$99.45 million (+14.75%). IOVA quarterly shareholders equity is now at all-time high.IOVA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.0% | +14.8% |
| 3 y3 years | -10.9% | +10.8% |
| 5 y5 years | +25.4% | +117.8% |
IOVA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.9% | +17.0% | at high | +96.4% |
| 5 y | 5 years | -10.9% | +95.5% | at high | +217.9% |
| alltime | all time | -10.9% | +4674.1% | at high | +4581.6% |
Iovance Biotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $773.46 M(+0.6%) |
| June 2024 | - | $768.54 M(+13.0%) |
| Mar 2024 | - | $680.02 M(+16.3%) |
| Dec 2023 | $584.61 M(+17.0%) | $584.61 M(-13.3%) |
| Sept 2023 | - | $674.01 M(+16.5%) |
| June 2023 | - | $578.57 M(-13.2%) |
| Mar 2023 | - | $666.88 M(+33.5%) |
| Dec 2022 | $499.64 M(-19.6%) | $499.64 M(+26.9%) |
| Sept 2022 | - | $393.74 M(-16.7%) |
| June 2022 | - | $472.69 M(-14.4%) |
| Mar 2022 | - | $551.99 M(-11.2%) |
| Dec 2021 | $621.66 M(-5.3%) | $621.66 M(-11.0%) |
| Sept 2021 | - | $698.33 M(-6.2%) |
| June 2021 | - | $744.41 M(+15.0%) |
| Mar 2021 | - | $647.43 M(-1.4%) |
| Dec 2020 | $656.50 M(+119.6%) | $656.50 M(-7.8%) |
| Sept 2020 | - | $711.84 M(-6.1%) |
| June 2020 | - | $758.31 M(+211.7%) |
| Mar 2020 | - | $243.31 M(-18.6%) |
| Dec 2019 | $298.97 M(-35.9%) | $298.97 M(-15.8%) |
| Sept 2019 | - | $355.06 M(-10.7%) |
| June 2019 | - | $397.42 M(-8.6%) |
| Mar 2019 | - | $434.93 M(-6.7%) |
| Dec 2018 | $466.19 M(+220.4%) | $466.19 M(+83.4%) |
| Sept 2018 | - | $254.16 M(-6.1%) |
| June 2018 | - | $270.57 M(-7.5%) |
| Mar 2018 | - | $292.56 M(+101.1%) |
| Dec 2017 | $145.48 M(-12.8%) | $145.48 M(-12.1%) |
| Sept 2017 | - | $165.44 M(+28.1%) |
| June 2017 | - | $129.15 M(-13.8%) |
| Mar 2017 | - | $149.89 M(-10.2%) |
| Dec 2016 | $166.92 M | $166.92 M(-6.8%) |
| Sept 2016 | - | $179.13 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $188.94 M(+91.0%) |
| Mar 2016 | - | $98.94 M(-4.9%) |
| Dec 2015 | $104.02 M(+132.0%) | $104.02 M(-4.9%) |
| Sept 2015 | - | $109.37 M(-3.1%) |
| June 2015 | - | $112.87 M(+1.1%) |
| Mar 2015 | - | $111.63 M(+148.9%) |
| Dec 2014 | $44.84 M(+154.7%) | $44.84 M(+177.5%) |
| Sept 2014 | - | $16.16 M(-7.0%) |
| June 2014 | - | $17.38 M(+3.4%) |
| Mar 2014 | - | $16.81 M(-4.5%) |
| Dec 2013 | $17.60 M(-255.5%) | $17.60 M(-627.0%) |
| Sept 2013 | - | -$3.34 M(+20.5%) |
| June 2013 | - | -$2.77 M(-77.4%) |
| Mar 2013 | - | -$12.28 M(+8.5%) |
| Dec 2012 | -$11.32 M(-11.4%) | -$11.32 M(-31.7%) |
| Sept 2012 | - | -$16.58 M(-0.2%) |
| June 2012 | - | -$16.62 M(-3.7%) |
| Mar 2012 | - | -$17.26 M(+35.0%) |
| Dec 2011 | -$12.78 M(-2103.0%) | -$12.78 M(+124.6%) |
| Sept 2011 | - | -$5.69 M(+305.3%) |
| June 2011 | - | -$1.40 M(-982.4%) |
| Mar 2011 | - | $159.10 K(-75.1%) |
| Dec 2010 | $638.10 K(-4826.7%) | $638.10 K(+42.4%) |
| Sept 2010 | - | $448.00 K(+7.2%) |
| June 2010 | - | $418.00 K(-16.6%) |
| Mar 2010 | - | $501.20 K(-3812.6%) |
| Dec 2009 | -$13.50 K(-687.0%) | -$13.50 K(+21.6%) |
| Sept 2009 | - | -$11.10 K(+44.2%) |
| June 2009 | - | -$7700.00(+79.1%) |
| Mar 2009 | - | -$4300.00(-287.0%) |
| Dec 2008 | $2300.00 | $2300.00(-86.1%) |
| Sept 2008 | - | $16.60 K(-13.1%) |
| June 2008 | - | $19.10 K(-44.0%) |
| Mar 2008 | - | $34.10 K |
FAQ
- What is Iovance Biotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual shareholders equity year-on-year change?
- What is Iovance Biotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly shareholders equity year-on-year change?
What is Iovance Biotherapeutics annual stockholders equity?
The current annual shareholders equity of IOVA is $584.61 M
What is the all time high annual shareholders equity for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual stockholders equity is $656.50 M
What is Iovance Biotherapeutics annual shareholders equity year-on-year change?
Over the past year, IOVA annual stockholders equity has changed by +$84.97 M (+17.01%)
What is Iovance Biotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of IOVA is $773.46 M
What is the all time high quarterly shareholders equity for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly stockholders equity is $773.46 M
What is Iovance Biotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, IOVA quarterly stockholders equity has changed by +$99.45 M (+14.75%)